We are live on
!
Find out more
MCM
Marathon Capital Management Portfolio holdings
AUM
$494M
1-Year Est. Return
42.6%
This Fund
S&P 500
This Quarter
Est. Return
-2.51%
1 Year Est. Return
+42.6%
3 Year Est. Return
+70.91%
5 Year Est. Return
+55.81%
10 Year Est. Return
+429.8%
AUM
$441M
AUM Growth
+$8.54M
(+2%)
Cap. Flow
+$29.5M
Cap. Flow
% of AUM
6.7%
Top 10 Holdings %
Top 10 Hldgs %
52.4%
Holding
236
New
37
Increased
77
Reduced
55
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Identive
INVE
|
+$4.66M |
| 2 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$3.06M |
| 3 |
ANI Pharmaceuticals
ANIP
|
+$2.31M |
| 4 |
Apple
AAPL
|
+$2.2M |
| 5 |
Microsoft
MSFT
|
+$1.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$3.11M |
| 2 |
CVA
Covanta Holding Corporation
CVA
|
+$1.22M |
| 3 |
RYM
RYTHM Inc
RYM
|
+$1.18M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$685K |
| 5 |
BlackRock Resources & Commodities Strategy Trust
BCX
|
+$610K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 47.82% |
| 2 | Technology | 15.24% |
| 3 | Healthcare | 11% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Discretionary | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
BioMarin Pharmaceuticals
BMRN
$12.4B
| – | – |
-2,500
| Closed | -$208K |
|
227
DXC Technology
DXC
$1.73B
| – | – |
-5,504
| Closed | -$214K |
|
228
GE Aerospace
GE
$384B
| – | – |
-2,203
| Closed | -$147K |
|
229
IPG Photonics
IPGP
$3.84B
| – | – |
-1,018
| Closed | -$214K |
|
|
MRSH
230
Marsh
MRSH
$91.5B
| – | – |
-1,745
| Closed | -$245K |
|
231
PRA Group
PRAA
$755M
| – | – |
-5,587
| Closed | -$214K |
|
232
Rocket Pharmaceuticals
RCKT
$394M
| – | – |
-5,672
| Closed | -$251K |
|
233
AT&T
T
$163B
| – | – |
-9,742
| Closed | -$211K |
|
|
CFMS
234
DELISTED
Conformis, Inc. Common Stock
CFMS
| – | – |
-400
| Closed | -$11K |
|
|
SAFM
235
DELISTED
Sanderson Farms Inc
SAFM
| – | – |
-1,620
| Closed | -$304K |
|
|
KOR
236
DELISTED
Corvus Gold Inc. Common Shares
KOR
| – | – |
-12,500
| Closed | -$34K |
|
Similar funds
LI
SAS
BFIC
FSA
TAM
TAA
NYLIC
MA
Marathon Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Marathon Capital Management held 236 positions worth $441M, up 2% from $432M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Marathon Capital Management deployed $29.5M of net new capital in Q3 2021, opening 37 new positions and adding to 77 existing holdings. Its largest new stake was Identive: 273,750 shares worth $5.16M.
By sector, the portfolio is most concentrated in Financials at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was T. Rowe Price, an estimated $3.11M trimmed.
- Marathon Capital Management's largest Q3 2021 buy was Identive: 273,750 shares worth $5.16M.
- Marathon Capital Management added most to Atlas Air Worldwide Holdings, Inc. in Q3 2021, an estimated $3.06M increase.
- Marathon Capital Management's biggest Q3 2021 reduction was T. Rowe Price, cutting an estimated $3.11M.
- Marathon Capital Management fully exited BlackRock Resources & Commodities Strategy Trust in Q3 2021, selling an estimated $610K.
- Marathon Capital Management's ten largest holdings make up 52% of its $441M portfolio in Q3 2021.
- Marathon Capital Management opened 37 new positions and closed 12 in Q3 2021.
- Marathon Capital Management's portfolio value rose 2% quarter-over-quarter to $441M.
Based on Marathon Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.